Anti Diabetic Products

About the Anti Diabetic range

Cista Medicorp is a WHO-GMP certified anti-diabetic PCD franchise company offering 47 oral antidiabetic formulations on district-wise monopoly rights across India.

The range covers every oral class in current use. Metformin in immediate, sustained and prolonged release. The sulfonylureas glimepiride and gliclazide. The DPP-4 inhibitors sitagliptin, vildagliptin, teneligliptin and linagliptin. The SGLT2 inhibitors dapagliflozin and empagliflozin. Pioglitazone, and the alpha-glucosidase inhibitors voglibose and acarbose. Most of the range is fixed-dose combination, built around metformin in two and three-drug tablets, because that is how type 2 diabetes is actually managed once a single agent stops holding HbA1c.

Diabetes is treated for decades, not months, and a patient stable on one batch has to stay stable on the next. Every batch is assayed for content uniformity and, for the modified-release products, for dissolution profile, because a release curve that drifts changes the medicine. Manufacturing is under GLP, WHO, ISO and GMP norms with raw material from approved vendors.

PCD pharma franchise and third-party manufacturing enquiries are welcome from anywhere in India. District-wise monopoly rights, promotional support and pan-India dispatch from Panchkula, Haryana.

Also searched as anti diabetic pcd franchise, diabetic pcd pharma company, anti diabetic products list, metformin sustained release tablets ip, glimepiride and metformin tablets, sitagliptin and metformin hydrochloride tablets.